BGMS - Rasio utang marang kapitalisasi buku Bio Green Med Solution Inc

Bio Green Med Solution Inc is developing targeted oncology therapy through strategic partnerships with medical institutions. These innovations are shaping a cell cycle inhibitor ecosystem to combat blood cancer. The debt-to-book capitalization ratio assessment on GURU.Markets confirms a financing structure where 0.00 reflects the baseline level of the metric. Currently, scaling is hindered by a lack of revenue and rising biolaboratory costs.

For Bio Green Med Solution Inc (BGMS), the leverage balance determines the funding stability for the development of oncology drugs. By analyzing the historical changes in the debt-to-equity ratio, an investor can see the proportion of borrowed funds relative to the company's own equity. A low ratio minimizes bankruptcy risk during prolonged clinical trials, while high leverage may accelerate the market launch of inhibitors. This metric assesses the business's ability to raise capital without sacrificing financial independence.